{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:56:51Z","timestamp":1791385011875,"version":"4.3.3"},"reference-count":61,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271 \\u2013 TRR 205"],"award-info":[{"award-number":["314061271 \\u2013 TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beem.2024.101913","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T14:02:50Z","timestamp":1720101770000},"page":"101913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Pre-clinical phaeochromocytoma and paraganglioma models: Cell lines, animal models, and a human primary culture model"],"prefix":"10.1016","volume":"38","author":[{"given":"Katharina","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessa","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Maccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanze","family":"Hantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley B.","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"N\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9486","key":"10.1016\/j.beem.2024.101913_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1245\/s10434-020-08220-3","article-title":"Update on pheochromocytoma and paraganglioma from the SSO endocrine\/head and neck disease-site work group. Part 1 of 2: advances in pathogenesis and diagnosis of pheochromocytoma and paraganglioma","volume":"27","author":"Patel","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1210\/endrev\/bnab019","article-title":"Personalized management of pheochromocytoma and paraganglioma","volume":"43","author":"N\u00f6lting","year":"2022","journal-title":"Endocr Rev"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib4","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1210\/jc.2018-01968","article-title":"Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono Study): a European network for the study of adrenal tumors retrospective study","volume":"104","author":"Hescot","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1530\/ERC-19-0024","article-title":"Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis","volume":"26","author":"Crona","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2024.101913_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/138573","article-title":"Profiling of somatic mutations in phaeochromocytoma and paraganglioma by targeted next generation sequencing analysis","volume":"2015","author":"Luchetti","year":"2015","journal-title":"Int J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11060809","article-title":"Optimizing genetic workup in pheochromocytoma and paraganglioma by integrating diagnostic and research approaches","volume":"11","author":"Gieldon","year":"2019","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.beem.2024.101913_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa502","article-title":"Sino-European differences in the genetic landscape and clinical presentation of pheochromocytoma and paraganglioma","volume":"105","author":"Jiang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","article-title":"Genomic landscape of pheochromocytoma and paraganglioma","volume":"4","author":"Jochmanova","year":"2018","journal-title":"Trends Cancer"},{"issue":"20","key":"10.1016\/j.beem.2024.101913_bib11","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","author":"Burnichon","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.beem.2024.101913_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-21-0355","article-title":"Personalized drug testing in human pheochromocytoma\/paraganglioma primary cultures","author":"Wang","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2024.101913_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae241","article-title":"Opposing effects of cannabidiol in patient-derived neuroendocrine tumor, pheochromocytoma\/paraganglioma primary cultures","author":"Wang","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101913_bib14","article-title":"Hypoxia-inducible factor 2alpha: a key player in tumorigenesis and metastasis of pheochromocytoma and paraganglioma?","author":"Bechmann","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"10.1016\/j.beem.2024.101913_bib15","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1210\/en.2019-00410","article-title":"Synergistic highly potent targeted drug combinations in different pheochromocytoma models including human tumor cultures","volume":"160","author":"Fankhauser","year":"2019","journal-title":"Endocrinology"},{"issue":"12","key":"10.1016\/j.beem.2024.101913_bib16","doi-asserted-by":"crossref","first-page":"R433","DOI":"10.1530\/ERC-19-0434","article-title":"Advances in paraganglioma-pheochromocytoma cell lines and xenografts","volume":"27","author":"Bayley","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"7","key":"10.1016\/j.beem.2024.101913_bib17","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.beem.2024.101913_bib18","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/MCB.15.7.3470","article-title":"The nerve growth factor-responsive PC12 cell line does not express the Myc dimerization partner Max","volume":"15","author":"Hopewell","year":"1995","journal-title":"Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.beem.2024.101913_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040958","article-title":"PC12 cell line: cell types, coating of culture vessels, differentiation and other culture conditions","volume":"9","author":"Wiatrak","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s004410000290","article-title":"Pheochromocytoma cell lines from heterozygous neurofibromatosis knockout mice","volume":"302","author":"Powers","year":"2000","journal-title":"Cell Tissue Res"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10585-009-9236-0","article-title":"Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signature","volume":"26","author":"Martiniova","year":"2009","journal-title":"Clin Exp Metastas--"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40246-017-0109-3","article-title":"The NF1 somatic mutational landscape in sporadic human cancers","volume":"11","author":"Philpott","year":"2017","journal-title":"Hum Genom"},{"issue":"10","key":"10.1016\/j.beem.2024.101913_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1530\/ERC-17-0212","article-title":"The microenvironment induces collective migration in SDHB-silenced mouse pheochromocytoma spheroids","volume":"24","author":"D'Antongiovanni","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00441-018-2907-x","article-title":"Primary fibroblast co-culture stimulates growth and metabolism in Sdhb-impaired mouse pheochromocytoma MTT cells","volume":"374","author":"Richter","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11050594","article-title":"Impact of extrinsic and intrinsic hypoxia on catecholamine biosynthesis in absence or presence of Hif2alpha in pheochromocytoma cells","volume":"11","author":"Bechmann","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1530\/ERC-19-0474","article-title":"A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+\/- rats","volume":"27","author":"Powers","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib28","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1023\/A:1006959625068","article-title":"First continuous human pheochromocytoma cell line: KNA. Biological, cytogenetic and molecular characterization of KNA cells","volume":"27","author":"Pfragner","year":"1998","journal-title":"J Neurocytol"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib29","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0405","article-title":"Progress and challenges in experimental models for pheochromocytoma and paraganglioma","volume":"30","author":"Tischler","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1210\/endo.139.2.5724","article-title":"KAT45, a noradrenergic human pheochromocytoma cell line producing corticotropin-releasing hormone","volume":"139","author":"Venihaki","year":"1998","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0360-3016(92)90545-S","article-title":"Radiosensitivity, repair capacity, and stem cell fraction in human soft tissue tumors: an in vitro study using multicellular spheroids and the colony assay","volume":"23","author":"Stuschke","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib32","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0360-3016(95)00528-7","article-title":"Heterogeneity in the fractionation sensitivities of human tumor cell lines: studies in a three-dimensional model system","volume":"32","author":"Stuschke","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beem.2024.101913_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1749-6632.1998.tb09581.x","article-title":"KAT45 human pheochromocytoma cell line. A new model for the in vitro study of neuro-immuno-hormonal interactions","volume":"840","author":"Venihaki","year":"1998","journal-title":"Ann N Y Acad Sci"},{"issue":"2-3","key":"10.1016\/j.beem.2024.101913_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(98)00834-6","article-title":"Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line","volume":"364","author":"Kampa","year":"1999","journal-title":"Eur J Pharm"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0360-3016(93)90347-X","article-title":"The TCD50 and regrowth delay assay in human tumor xenografts: differences and implications","volume":"25","author":"Budach","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065624","article-title":"Progenitor cell line (hPheo1) derived from a human pheochromocytoma tumor","volume":"8","author":"Ghayee","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s007950200006","article-title":"Ultrastructure of human pheochromocytoma cells cultured for long periods","volume":"35","author":"Nakada","year":"2002","journal-title":"Med Electron Microsc"},{"issue":"9","key":"10.1016\/j.beem.2024.101913_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274478","article-title":"Long-term in vitro 2D-culture of SDHB and SDHD-related human paragangliomas and pheochromocytomas","volume":"17","author":"Bayley","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib39","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/0196-9781(91)90063-U","article-title":"Human pheochromocytoma cells studied in culture contain large amounts of DSIP-like material","volume":"12","author":"Nilsson","year":"1991","journal-title":"Peptides"},{"key":"10.1016\/j.beem.2024.101913_bib40","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad166","article-title":"Metastatic pheochromocytoma and paraganglioma: Somatostatin receptor 2 expression, genetics and therapeutic responses","author":"Fischer","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib41","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/ejendo\/lvad146","article-title":"Responses to systemic therapy in metastatic pheochromocytoma\/paraganglioma: a retrospective multicenter cohort study","volume":"189","author":"Fischer","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"21","key":"10.1016\/j.beem.2024.101913_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15215199","article-title":"PD-L1 and HIF-2alpha upregulation in head and neck paragangliomas after embolization","volume":"15","author":"Fischer","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000507669","article-title":"Three-dimensional primary cell culture: a novel preclinical model for pancreatic neuroendocrine tumors","volume":"111","author":"April-Monn","year":"2021","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.beem.2024.101913_bib44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/EJE-09-0596","article-title":"Synaptophysin immunoreactivity in adrenocortical adenomas: a correlation between synaptophysin and CYP17A1 expression","volume":"161","author":"Shigematsu","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib45","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/bcp.12378","article-title":"Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3-kinase antagonist, in adult patients with advanced solid malignancies","volume":"78","author":"De Buck","year":"2014","journal-title":"Br J Clin Pharm"},{"issue":"11","key":"10.1016\/j.beem.2024.101913_bib46","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-13-0043","article-title":"A proposal regarding reporting of in vitro testing results","volume":"19","author":"Smith","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"18","key":"10.1016\/j.beem.2024.101913_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15184601","article-title":"Three dimensional models of endocrine organs and target tissues regulated by the endocrine system","volume":"15","author":"Luca","year":"2023","journal-title":"Cancers"},{"issue":"7_Supplement","key":"10.1016\/j.beem.2024.101913_bib48","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-195","article-title":"Abstract 195: establishment and validation of pheochromocytoma organoids for high-throughput drug screening","volume":"83","author":"Calucho","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.beem.2024.101913_bib49","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.3389\/fimmu.2020.01235","article-title":"Adrenergic signaling in Circadian control of immunity","volume":"11","author":"Leach","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.beem.2024.101913_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110453","article-title":"SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB\/NF1 loss yields SDHx-like pheochromocytomas","volume":"38","author":"Armstrong","year":"2022","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/j.beem.2024.101913_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ng0794-353","article-title":"Tumour predisposition in mice heterozygous for a targeted mutation in Nf1","volume":"7","author":"Jacks","year":"1994","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib52","first-page":"450","article-title":"Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome","volume":"52","author":"Schulz","year":"1992","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/ERC-20-0308","article-title":"Loss of sdhb in zebrafish larvae recapitulates human paraganglioma characteristics","volume":"28","author":"Dona","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"2","key":"10.1016\/j.beem.2024.101913_bib54","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.canlet.2014.07.005","article-title":"Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model","volume":"352","author":"Denorme","year":"2014","journal-title":"Cancer Lett"},{"issue":"14","key":"10.1016\/j.beem.2024.101913_bib55","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.18632\/oncotarget.16224","article-title":"Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway","volume":"8","author":"Pang","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.beem.2024.101913_bib56","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/en.2014-1027","article-title":"Combination of 13-Cis retinoic acid and lovastatin: marked antitumor potential in vivo in a pheochromocytoma allograft model in female athymic nude mice","volume":"155","author":"N\u00f6lting","year":"2014","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.beem.2024.101913_bib57","first-page":"3669","article-title":"The antiangiogenic agent linomide inhibits the growth rate of von Hippel-Lindau paraganglioma xenografts to mice","volume":"5","author":"Gross","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101913_bib58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12022-016-9452-5","article-title":"Pathology of human pheochromocytoma and paraganglioma xenografts in NSG mice","volume":"28","author":"Powers","year":"2017","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.beem.2024.101913_bib59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00401-017-1799-2","article-title":"Paragangliomas arise through an autonomous vasculo-angio-neurogenic program inhibited by imatinib","volume":"135","author":"Verginelli","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.beem.2024.101913_bib60","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1196\/annals.1353.034","article-title":"Animal models of pheochromocytoma including NIH initial experience","volume":"1073","author":"Ohta","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.beem.2024.101913_bib61","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother Rep"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:03:47Z","timestamp":1778616227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521690X24000678"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101913","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-clinical phaeochromocytoma and paraganglioma models: Cell lines, animal models, and a human primary culture model","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101913","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101913"}}